Home Icon
Ha Noi CPC1 Pharmaceutical JSCLeading Pharmaceutical Technology
(+84) 98 440 46 50


Active Element: Digoxin 0.05mg/ml

Dosage Form:

Oral solution

Cardiac failure
Digoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. Its
therapeutic benefit is greatest in those patients with ventricular dilatation.
Digoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation.
Supraventricular arrhythmias
Digoxin is indicated in the management of certain supraventricular arrhythmias, particularly chronic atrial flutter andfibrillation.

Related Products

Ha Noi CPC1 Pharmaceutical JSC
Contact Us
Ha Noi CPC1 Pharmaceutical JSCHa Binh Phuong Industrial Zone, Thuong Tin District, Hanoi, VietnamWhatsApp/Viber/Mobile: (+84) 98 440 46 50
Copyright © CPC1HN 2024